Multiple myeloma (MM) affects over 5,500 people annually in the UK, with a 5-year survival rate below 50% in advanced stages. Resistance to therapies is driven by transcriptional addiction, where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback